NKG2C/CD159c hFc Chimera, Human
NKG2C/CD159c HFc Chimera, Human

The purity of NKG2C/CD159c hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

NKG2C/CD159c HFc Chimera, Human

NKG2C/CD159c hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

NKG2C/CD159c hFc Chimera, Human

As a first line of defense, natural killer (NK) cells play a crucial role in the fight against infections.The presented study is the first of its kind that ascribes CD56dimCD16 NKG2C-expressing NK cells a crucial role in biasing adaptive immune responses upon influenza vaccination and suggests NKG2C as a potential biomarker in predicting pandemic influenza vaccine responsiveness.
Z05689
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
NKG2C/CD159c (Glu98-Leu231)_x000D_
Accession # P26717		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 42.07 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 48-58 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • NKG2C/CD159c HFc Chimera, Human
    • NKG2C/CD159c HFc Chimera, Human

    The purity of NKG2C/CD159c hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

  • NKG2C/CD159c HFc Chimera, Human
    • NKG2C/CD159c HFc Chimera, Human

    NKG2C/CD159c hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background As a first line of defense, natural killer (NK) cells play a crucial role in the fight against infections.The presented study is the first of its kind that ascribes CD56dimCD16 NKG2C-expressing NK cells a crucial role in biasing adaptive immune responses upon influenza vaccination and suggests NKG2C as a potential biomarker in predicting pandemic influenza vaccine responsiveness.
Synonyms CD159c; KLRC2; NKG2C; NK cell receptor C

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.